Description
| Product Name | CAT.No | Size |
| COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) | COVID010 | 10T |
| COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) | COVID020 | 20T |
| COVID-19 Ag Nasal/Nasopharyngeal Swab Cassette | COVNS020 | 20T |
| Influenza & COVID-10 Ag Combo (Nasopharyngeal) | COVIC020 | 20T |
| Influenza & COVID-10 Ag Combo Rapid Test (Nasal) | COVICN20 | 20T |
Product Description
The Biorex Diagnostics COVID-19 Rapid Tests are rapid immunochromatographic assays designed for the qualitative detection of SARS-CoV-2 antigens or antibodies in human nasal swab, serum, plasma, or whole blood samples. These assays provide fast, reliable, and clinically relevant results, supporting early diagnosis, infection control, and public health monitoring in a variety of healthcare and point-of-care settings. By enabling timely detection of active infection or prior exposure, the tests help clinicians, laboratories, and healthcare providers make informed decisions regarding patient management, isolation measures, and outbreak response.
Key Features
- Rapid Detection – delivers qualitative results within 10–15 minutes, facilitating immediate clinical assessment.
- Antigen and Antibody Options – nasal swab testing identifies active viral infection, while serum, plasma, or whole blood testing detects IgG/IgM antibodies for prior exposure or immune response.
- High Sensitivity and Specificity – accurately identifies SARS-CoV-2 with minimal false positives or negatives, ensuring diagnostic confidence.
- Instrument-Free Operation – suitable for point-of-care, laboratory, or field deployment without the need for specialised equipment.
- Ready-to-Use Format – minimal preparation, simple visual interpretation, and reduced handling errors streamline testing workflows.
Benefits
Routine use of the Biorex Rapid Tests allows for early recognition of SARS-CoV-2 infections, enabling prompt clinical intervention and supporting infection prevention measures. Their rapid workflow and ease of use make them ideal for hospitals, clinics, mobile testing units, and community health programs. By providing reliable preliminary results, the assays facilitate efficient patient triage, mass screening campaigns, and epidemiological surveillance, helping healthcare providers manage resources effectively and reduce the risk of community transmission. The versatility of sample types ensures adaptability in diverse clinical and laboratory environments, while the instrument-free design allows deployment in remote or resource-limited areas. With high sensitivity, specificity, and consistent performance, the Biorex Rapid Tests contribute to safer patient care, informed decision-making, and strengthened public health outcomes.
Contact Us for more information.